ACM
TMO icon

Ascendant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Ascendant Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,700
Closed -$1.69M – 74
2021
Q1 		$1.69M Buy
3,700
+700
+23% +$334K 1.48% 28
2020
Q4 		$1.4M Buy
+3,000
New +$1.41M 1.19% 35

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ascendant Capital Management's TMO Position: Q2 2021 in Review

Ascendant Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 3,700 shares — an estimated $1.69M sold.

Ascendant Capital Management first reported a position in TMO in Q4 2020 and held it in 2 quarters. The position peaked at $1.69M in Q1 2021. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Ascendant Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • Ascendant Capital Management sold 3,700 Thermo Fisher Scientific shares in Q2 2021, an estimated $1.69M.
  • Ascendant Capital Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 2 quarters.
  • Ascendant Capital Management's Thermo Fisher Scientific position peaked at $1.69M in Q1 2021.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Ascendant Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.